Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 27


Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process.

Saing T, Lagman M, Castrillon J, Gutierrez E, Guilford FT, Venketaraman V.

BBA Clin. 2016 May 29;6:38-44. doi: 10.1016/j.bbacli.2016.05.006. eCollection 2016 Dec.


Complement 3 Receptor Expression in Individuals with Type 2 Diabetes.

Ly J, Morris D, Lagman M, Christopher N, Anderson S, Daliva J, Muwanas N, Tarash I, Ochoa C, Sathananthan A, Venketaraman V.

Recent Pat Antiinfect Drug Discov. 2016 Jun 8. [Epub ahead of print]


Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis - A Close View of the Immune System.

Venketaraman V.

Front Immunol. 2015 Oct 22;6:545. doi: 10.3389/fimmu.2015.00545. eCollection 2015. No abstract available.


Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione.

Allen M, Bailey C, Cahatol I, Dodge L, Yim J, Kassissa C, Luong J, Kasko S, Pandya S, Venketaraman V.

Front Immunol. 2015 Oct 5;6:508. doi: 10.3389/fimmu.2015.00508. eCollection 2015. Review.


Mycobacterium tuberculosis.

Venketaraman V, Kaushal D, Saviola B.

J Immunol Res. 2015;2015:857598. doi: 10.1155/2015/857598. Epub 2015 Aug 4. No abstract available.


Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals.

Ly J, Lagman M, Saing T, Singh MK, Tudela EV, Morris D, Anderson J, Daliva J, Ochoa C, Patel N, Pearce D, Venketaraman V.

J Interferon Cytokine Res. 2015 Nov;35(11):875-87. doi: 10.1089/jir.2014.0210. Epub 2015 Jul 2.


Investigating the causes for decreased levels of glutathione in individuals with type II diabetes.

Lagman M, Ly J, Saing T, Kaur Singh M, Vera Tudela E, Morris D, Chi PT, Ochoa C, Sathananthan A, Venketaraman V.

PLoS One. 2015 Mar 19;10(3):e0118436. doi: 10.1371/journal.pone.0118436. eCollection 2015.


Glutathione synthesis is compromised in erythrocytes from individuals with HIV.

Morris D, Ly J, Chi PT, Daliva J, Nguyen T, Soofer C, Chen YC, Lagman M, Venketaraman V.

Front Pharmacol. 2014 Apr 11;5:73. doi: 10.3389/fphar.2014.00073. eCollection 2014.


An elucidation of neutrophil functions against Mycobacterium tuberculosis infection.

Morris D, Nguyen T, Kim J, Kassissa C, Khurasany M, Luong J, Kasko S, Pandya S, Chu M, Chi PT, Ly J, Lagman M, Venketaraman V.

Clin Dev Immunol. 2013;2013:959650. doi: 10.1155/2013/959650. Epub 2013 Nov 7.


Characterization of dendritic cell and regulatory T cell functions against Mycobacterium tuberculosis infection.

Morris D, Gonzalez B, Khurasany M, Kassissa C, Luong J, Kasko S, Pandya S, Chu M, Chi PT, Bui S, Guerra C, Chan J, Venketaraman V.

Biomed Res Int. 2013;2013:402827. doi: 10.1155/2013/402827. Epub 2013 May 23.


Glutathione supplementation improves macrophage functions in HIV.

Morris D, Guerra C, Khurasany M, Guilford F, Saviola B, Huang Y, Venketaraman V.

J Interferon Cytokine Res. 2013 May;33(5):270-9. doi: 10.1089/jir.2012.0103. Epub 2013 Feb 14.


Glutathione and infection.

Morris D, Khurasany M, Nguyen T, Kim J, Guilford F, Mehta R, Gray D, Saviola B, Venketaraman V.

Biochim Biophys Acta. 2013 May;1830(5):3329-49. doi: 10.1016/j.bbagen.2012.10.012. Epub 2012 Oct 23. Review.


Unveiling the mechanisms for decreased glutathione in individuals with HIV infection.

Morris D, Guerra C, Donohue C, Oh H, Khurasany M, Venketaraman V.

Clin Dev Immunol. 2012;2012:734125. doi: 10.1155/2012/734125. Epub 2011 Dec 29.


Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals.

Guerra C, Morris D, Sipin A, Kung S, Franklin M, Gray D, Tanzil M, Guilford F, Khasawneh FT, Venketaraman V.

PLoS One. 2011;6(12):e28378. doi: 10.1371/journal.pone.0028378. Epub 2011 Dec 2.


Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA).

Pumerantz A, Muppidi K, Agnihotri S, Guerra C, Venketaraman V, Wang J, Betageri G.

Int J Antimicrob Agents. 2011 Feb;37(2):140-4. doi: 10.1016/j.ijantimicag.2010.10.011. Epub 2010 Dec 3.


Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection.

Guilford T, Morris D, Gray D, Venketaraman V.

HIV AIDS (Auckl). 2010;2:211-8. doi: 10.2147/HIV.S11977. Epub 2010 Oct 29.


Control of mycobacterium tuberculosis infection by glutathione.

Connell ND, Venketaraman V.

Recent Pat Antiinfect Drug Discov. 2009 Nov;4(3):214-26. Review.


Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing.

Venketaraman V, Lin AK, Le A, Kachlany SC, Connell ND, Kaplan JB.

Microb Pathog. 2008 Sep;45(3):173-80. doi: 10.1016/j.micpath.2008.05.007. Epub 2008 Jun 5.


Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis.

Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V.

J Interferon Cytokine Res. 2008 Mar;28(3):153-65. doi: 10.1089/jir.2007.0095.


Glutathione levels and immune responses in tuberculosis patients.

Venketaraman V, Millman A, Salman M, Swaminathan S, Goetz M, Lardizabal A, David Hom, Connell ND.

Microb Pathog. 2008 Mar;44(3):255-61. Epub 2007 Sep 26.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk